Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
Survey findings released in advance of World Lupus Day on May 10
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The report has estimated 4.74 million deaths for India in 2020 and 2021,
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May
Subscribe To Our Newsletter & Stay Updated